Venture Capital interview preparation
Sourcing, unit economics, term sheets, cap tables, fund economics and the India venture market. Every question is either traced to a named firm from a public candidate report, or tagged at desk level when we could not trace it — answers lead with the point, then the mechanism, then the limitation.
100 questions, mapped to the firms that asked them
- Questions
- 100
- Traced to a firm
- 31
- Firms
- 12
- Updated
- September 2026
047Why would a distressed company have a high equity value?Silver LakeTechnology, Media and Telecom · San Francisco · 2022
Say this
Because equity in a levered company is a call option on the enterprise value, and an option has value even when it is deep out of the money. If there is any chance the business recovers enough to clear the debt, the equity is worth something, and the more volatile the outcome the more that option is worth.
Then walk it
- Set it up as the option: equity value equals the enterprise value less the debt, floored at zero. That is exactly the payoff of a call struck at the face value of the debt. Limited liability is what creates the floor.
- So even if enterprise value today is $800m against $1bn of debt, the equity is not worth zero. It is worth the option premium — the probability-weighted value of the scenarios where the business recovers above $1bn before the debt matures.
- And the counterintuitive consequence: volatility increases the equity value. A distressed company with a wildly uncertain outcome has more valuable equity than an equally distressed company with a certain modest decline, because only the upside tail accrues to the equity while the downside is the creditors' problem.
- Which explains the behaviour you see in distressed situations: management and equity holders favour risky strategies, because they capture the upside and creditors eat the downside. That is the classic risk-shifting conflict, and it is why credit agreements have covenants.
- Time to maturity also matters, same as an option. Debt maturing in five years gives the equity far more optionality than debt maturing in six months, which is why the maturity wall, not the leverage ratio, is usually what actually triggers a restructuring.
- The other mundane reasons a screen might show a high equity value on a distressed company: a large cash balance that has not been marked against the operating decline, an unconsolidated stake or real estate worth more than the operating business, or a retail-driven share price detached from the fundamentals. Worth naming, but the option answer is the one they want.
Where candidates lose it
Answering only with the mundane explanations — hidden assets, cash on the balance sheet. Those are real but this question is testing whether you see equity as a call option on enterprise value. Get to the option framing first, then add that volatility raises the equity value, which is the part that separates a good answer from a complete one.
Expect next
- What happens to that option as the debt maturity gets closer?
- Why do equity holders in a distressed company favour risky strategies?
- How would you value the debt in that situation?
Reported by candidates at Silver Lake (Technology, Media and Telecom, San Francisco, 2022). Source: Wall Street Oasis.
054An oil company loses forty million dollars of market capitalisation because of litigation, then sells an asset to pay for it. Is the share price drop justified?Silver LakeTechnology, Media and Telecom · San Francisco · 2022
Say this
A $40m drop is justified only if the expected after-tax cash cost of the litigation is about $40m and nothing else changed. The asset sale is a separate question: if the asset was sold at fair value, the sale itself destroys no value and the share price should not move again for it.
Then walk it
- First, price the liability properly. What matters is the probability-weighted, after-tax, present value of the cash outflow, plus any legal costs, less insurance recovery. A $40m headline settlement at a 25 percent tax rate and 70 percent probability is closer to $21m of economic cost.
- Second, ask whether the litigation revealed something. If it signals an ongoing practice that will generate more claims, or a regulatory exposure across the asset base, the drop should exceed the direct cost — the market is repricing future cash flows, not just paying a fine. That is usually the real answer for litigation-driven drops.
- Third, the asset sale. Selling an asset at fair value is value-neutral: you swap an asset for cash of equal value. Enterprise value falls by the asset's value, cash rises, equity value is unchanged.
- But sold at a discount, which is what a forced seller does, it is value-destructive twice over — once for the discount and once for the loss of an asset that may have been worth more inside the portfolio than to the buyer. A distressed sale to fund a settlement is a classic way a $40m problem becomes a $60m one.
- Then the tax detail worth mentioning for an oil asset: a sale can trigger a large gain against a low tax basis, so the after-tax proceeds can be materially less than the headline price, and the company may need to sell more than $40m of assets to net $40m.
- So the structured answer is: justified if the drop equals the after-tax expected cost and the litigation is genuinely one-off. Understated if it signals a systemic problem. Overstated if the market priced the headline number rather than the probability-weighted after-tax figure, which markets frequently do on litigation news.
Where candidates lose it
Answering yes or no. This is a framework question and the only wrong answer is an unconditional one. The two things you must separate are the cost of the liability and the information content of the litigation, and you must state that a fair-value asset sale is value-neutral while a forced one is not.
Expect next
- What if the asset was sold at a 20 percent discount to fair value?
- How would you price the litigation if the outcome is binary?
- Does the asset sale change enterprise value or equity value?
Reported by candidates at Silver Lake (Technology, Media and Telecom, San Francisco, 2022). Source: Wall Street Oasis.
079Pitch me a company that is not in our portfolio that we should invest in.Insight PartnersSoftware · New York · 2022Insight PartnersLeveraged Buyouts · New York · 2023General AtlanticGrowth Equity · New York · 2022General AtlanticGrowth Equity · New York · 2021Silver LakeTechnology, Media and Telecom · San Francisco · 2022
Say this
Structure it in five beats and keep it to three minutes: the shift in the world, the company and its wedge, the evidence it is working, why it fits this firm's mandate, and what would kill it. Then stop and let them interrogate it — the pitch is the setup, the cross-examination is the actual test.
Then walk it
- Beat one, the shift: what changed in the last two years that makes this possible and did not before. Regulation, a cost curve, a behaviour change, a platform. Without a 'why now', it is a feature, not a company.
- Beat two, the company and the wedge: what they sell, to whom, and why they win that first narrow segment. Be specific about the wedge — 'AI for healthcare' is not a wedge; 'prior-authorisation automation for mid-sized orthopaedic practices' is.
- Beat three, the evidence, with numbers and their source: revenue or run rate, growth, retention if you can find it, headcount trend from LinkedIn, app-store ranking, review velocity, whatever is observable. Say where each number came from. Two real numbers beat a page of narrative.
- Beat four, why this firm: stage, cheque size, sector fit, and what the firm specifically brings. If they lead $30m growth rounds, do not pitch a pre-seed. This beat is what separates a prepared candidate from someone reciting a favourite company.
- Beat five, the bear case and the price. Name the two things that would kill it, say what you would diligence first, and give a valuation view — what you would pay and why. A pitch with no price is not an investment recommendation.
- Then the return maths, briefly, because it is what they will ask: what has to be true for this to be a 10x. If you cannot get to a fund-returning outcome, say so and explain why it is still interesting, or pick a different company.
Where candidates lose it
Pitching a company already in their portfolio, or a household name where you have no edge. Check the portfolio page first. The second trap is describing the product for two minutes and never giving an investment view: no price, no bear case, no return maths. And pick something checkable — if you claim a revenue figure, know where it came from, because they will ask.
Expect next
- What would you pay for it, and what would you not pay?
- What is the strongest argument against this investment?
- What would you diligence first, and who would you call?
Reported by candidates at Insight Partners (Software, New York, 2022); Insight Partners (Leveraged Buyouts, New York, 2023); General Atlantic (Growth Equity, New York, 2022); General Atlantic (Growth Equity, New York, 2021); Silver Lake (Technology, Media and Telecom, San Francisco, 2022). Source: Wall Street Oasis.
Firm tags come from public, anonymous candidate reports on Wall Street Oasis: strong signal, not sworn testimony. Firms are named as the places a question was reported, not as partners of Fin Maverick. Answers are written for this page to show how to think out loud; they are not scripts to recite.
